Yanwen Chen

ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 4

Top Venues

Research square

Nature chemical biology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Yuan Liu, Michael J Jurczak, Travis B Lear, Bo Lin, Mads B Larsen, Jason R Kennerdell, Yanwen Chen, Brydie R Huckestein, Matthew K Nguyen, Ferhan Tuncer, Yu Jiang, Satdarshan Paul Monga, Christopher P O'Donnell, Toren Finkel, Bill B Chen, Rama K Mallampalli
A Fbxo48 inhibitor prevents pAMPKα degradation and ameliorates insulin resistance. Nature chemical biology 17 (3) (2021)
Yuan Liu, Travis Lear, Mads B Larsen, Bo Lin, Qing Cao, Irene Alfaras, Jason Kennerdell, Laura Salminen, Daniel Camarco, Karina Lockwood, Jing Ma, Jie Liu, Jay Xiaojun Tan, Michael Myerburg, Yanwen Chen, Claudette St Croix, Yusuke Sekine, John Evankovich, Toren Finkel, Bill B Chen
Modulation of lysosomal function as a therapeutic approach for coronaviral infections. Research square (2021)
Yanwen Chen, Travis B Lear, John W Evankovich, Mads B Larsen, Bo Lin, Irene Alfaras, Jason R Kennerdell, Laura Salminen, Daniel P Camarco, Karina C Lockwood, Ferhan Tuncer, Jie Liu, Michael M Myerburg, John F McDyer, Yuan Liu, Toren Finkel, Bill B Chen
A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry. Nature communications 12 (1) (2021)
Yanwen Chen, Travis B Lear, John W Evankovich, Mads Larsen, Bo Lin, Irene Alfaras, Jason Kennerdell, Laura Salminen, Daniel Camarco, Karina Lockwood, Jie Liu, Michael Myerburg, John McDyer, Yuan Liu, Toren Finkel, Bill Chen
A high throughput screen for TMPRSS2 expression identifies FDA-approved and clinically advanced compounds that can limit SARS-CoV-2 entry. Research square (2020)

Yanwen Chen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yanwen Chen